| Media, News, Press Release

【Successful Development of Pathology AI】Now Possible for Highly Accurate Detection of Adenocarcinoma in Multiple Organs – Published in PLOS ONE

Medmain Inc., a provider of the digital pathology support solution called “PidPort”, has successfully developed a pathological AI that enables to classify adenocarcinoma with high accuracy in digital histopathology for multi-organ (stomach, colon, lung, breast, lymph nodes) by using “Weakly Supervised Learning,” a learning style of Deep Learning.
We are also pleased to announce that a paper on this development has been posted on PLOS ONE, issued by PLOS (, and published on November 23, 2022.

*This achievement was made possible by a grant from the New Energy and Industrial Technology Development Organization (NEDO).